Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients

Background: Although regular blood transfusion enhances the overall survival of thalassaemia patients, it have a significant threat of infection with transfusion-related infections, including hepatitis C; therefore, screening is mandatory. Routine screening with anti-hepatitis C Ab was recommended ...

Full description

Bibliographic Details
Main Authors: Abdulrazzaq Mustafa Abbas, Najdat Shukur Mahmood, Dawood Salman Al-Azzawi
Format: Article
Language:English
Published: College of medicine/ University of Diyala 2019-05-01
Series:Diyala Journal of Medicine
Subjects:
Online Access:https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/236
_version_ 1797586321212964864
author Abdulrazzaq Mustafa Abbas
Najdat Shukur Mahmood
Dawood Salman Al-Azzawi
author_facet Abdulrazzaq Mustafa Abbas
Najdat Shukur Mahmood
Dawood Salman Al-Azzawi
author_sort Abdulrazzaq Mustafa Abbas
collection DOAJ
description Background: Although regular blood transfusion enhances the overall survival of thalassaemia patients, it have a significant threat of infection with transfusion-related infections, including hepatitis C; therefore, screening is mandatory. Routine screening with anti-hepatitis C Ab was recommended  many years ago; sometimes they depend on level of liver enzymes. Objective: To evaluate the clinical and biochemical features of seropositive hepatitis C virus infection in multi-transfused β-thalassaemia patients to verify if they can be used as a guidance for screening. Patients and Methods: A retrospective- study done from June to September of 2014 at Thalassaemia Center in Baqubah city - Diyala province - Iraq. All registered                     β- thalassaemia major and intermedia patients were included, involving adults. Enzyme linked immunosorbant assay was used to screen for hepatitis C virus. Symptoms, signs, and biochemical features, including liver transaminases level, of sero-positive patients were gathered and analyzed. Descriptive statistical analysis and Pearson chi- square test was appliedto analyze data by using Statistical Package for Social Sciences software, version 16. Results: The total enrolled subjects were 215, male gender comprises 54.9% (n=118); most of the included patients were under 12 years old. The results indicate that 11.2%(n= 24) of multi-transfused β- thalassaemia patients showed serological evidence of hepatitis C. The highest anti-HCV prevalence was observed  at ≥ 18 years old patients (p value=.000). More than two third of cases were male gender (p value=.041), but the gender was not associated with positive serology for hepatitis C in the whole sample of the study (p value=.096). All anti-HCV positive patients were clinically asymptomatic;  biochemically, 75% (n=18) of them had normal liver transaminases levels (p value=. 014). Conclusion: Asymptomatic clinical status and unreliable transaminases level elevation cannot be helpful as directory for screening, we encourage the continuation of the usual routine screening test by enzyme linked immunosorbant assay for hepatitis C in                 β-thalassemia patients; it is more crucial for an older patient.
first_indexed 2024-03-11T00:21:40Z
format Article
id doaj.art-83b81c87ce6841c0b0b2279e19986651
institution Directory Open Access Journal
issn 2219-9764
2617-8982
language English
last_indexed 2024-03-11T00:21:40Z
publishDate 2019-05-01
publisher College of medicine/ University of Diyala
record_format Article
series Diyala Journal of Medicine
spelling doaj.art-83b81c87ce6841c0b0b2279e199866512023-11-18T23:17:44ZengCollege of medicine/ University of DiyalaDiyala Journal of Medicine2219-97642617-89822019-05-01102Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia PatientsAbdulrazzaq Mustafa AbbasNajdat Shukur MahmoodDawood Salman Al-Azzawi Background: Although regular blood transfusion enhances the overall survival of thalassaemia patients, it have a significant threat of infection with transfusion-related infections, including hepatitis C; therefore, screening is mandatory. Routine screening with anti-hepatitis C Ab was recommended  many years ago; sometimes they depend on level of liver enzymes. Objective: To evaluate the clinical and biochemical features of seropositive hepatitis C virus infection in multi-transfused β-thalassaemia patients to verify if they can be used as a guidance for screening. Patients and Methods: A retrospective- study done from June to September of 2014 at Thalassaemia Center in Baqubah city - Diyala province - Iraq. All registered                     β- thalassaemia major and intermedia patients were included, involving adults. Enzyme linked immunosorbant assay was used to screen for hepatitis C virus. Symptoms, signs, and biochemical features, including liver transaminases level, of sero-positive patients were gathered and analyzed. Descriptive statistical analysis and Pearson chi- square test was appliedto analyze data by using Statistical Package for Social Sciences software, version 16. Results: The total enrolled subjects were 215, male gender comprises 54.9% (n=118); most of the included patients were under 12 years old. The results indicate that 11.2%(n= 24) of multi-transfused β- thalassaemia patients showed serological evidence of hepatitis C. The highest anti-HCV prevalence was observed  at ≥ 18 years old patients (p value=.000). More than two third of cases were male gender (p value=.041), but the gender was not associated with positive serology for hepatitis C in the whole sample of the study (p value=.096). All anti-HCV positive patients were clinically asymptomatic;  biochemically, 75% (n=18) of them had normal liver transaminases levels (p value=. 014). Conclusion: Asymptomatic clinical status and unreliable transaminases level elevation cannot be helpful as directory for screening, we encourage the continuation of the usual routine screening test by enzyme linked immunosorbant assay for hepatitis C in                 β-thalassemia patients; it is more crucial for an older patient. https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/236β-thalassaemia, hepatitis C virus, serology, screening test
spellingShingle Abdulrazzaq Mustafa Abbas
Najdat Shukur Mahmood
Dawood Salman Al-Azzawi
Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
Diyala Journal of Medicine
β-thalassaemia, hepatitis C virus, serology, screening test
title Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
title_full Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
title_fullStr Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
title_full_unstemmed Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
title_short Reliability of Clinical Aspect and Transaminases Level as a Guidance for Screening for Sero-positive Hepatitis C in Multi-transfused β-Thalassaemia Patients
title_sort reliability of clinical aspect and transaminases level as a guidance for screening for sero positive hepatitis c in multi transfused β thalassaemia patients
topic β-thalassaemia, hepatitis C virus, serology, screening test
url https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/236
work_keys_str_mv AT abdulrazzaqmustafaabbas reliabilityofclinicalaspectandtransaminaseslevelasaguidanceforscreeningforseropositivehepatitiscinmultitransfusedbthalassaemiapatients
AT najdatshukurmahmood reliabilityofclinicalaspectandtransaminaseslevelasaguidanceforscreeningforseropositivehepatitiscinmultitransfusedbthalassaemiapatients
AT dawoodsalmanalazzawi reliabilityofclinicalaspectandtransaminaseslevelasaguidanceforscreeningforseropositivehepatitiscinmultitransfusedbthalassaemiapatients